NO20065030L - Aerosolformulering for inhalering av beta agonister. - Google Patents

Aerosolformulering for inhalering av beta agonister.

Info

Publication number
NO20065030L
NO20065030L NO20065030A NO20065030A NO20065030L NO 20065030 L NO20065030 L NO 20065030L NO 20065030 A NO20065030 A NO 20065030A NO 20065030 A NO20065030 A NO 20065030A NO 20065030 L NO20065030 L NO 20065030L
Authority
NO
Norway
Prior art keywords
inhalation
aerosol formulation
beta agonists
agonists
beta
Prior art date
Application number
NO20065030A
Other languages
English (en)
Norwegian (no)
Inventor
Michael Aven
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34979667&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20065030(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of NO20065030L publication Critical patent/NO20065030L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/536—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines ortho- or peri-condensed with carbocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/04—Amoebicides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Dispersion Chemistry (AREA)
  • Dermatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
NO20065030A 2004-05-14 2006-11-02 Aerosolformulering for inhalering av beta agonister. NO20065030L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102004024452A DE102004024452A1 (de) 2004-05-14 2004-05-14 Aerosolformulierung für die Inhalation von Betaagonisten
PCT/EP2005/005028 WO2005110421A2 (de) 2004-05-14 2005-05-10 Aerosolformulierung für die inhalation von betaagonisten

Publications (1)

Publication Number Publication Date
NO20065030L true NO20065030L (no) 2006-11-30

Family

ID=34979667

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20065030A NO20065030L (no) 2004-05-14 2006-11-02 Aerosolformulering for inhalering av beta agonister.

Country Status (26)

Country Link
EP (1) EP1809293B1 (es)
JP (1) JP4620730B2 (es)
KR (1) KR101288791B1 (es)
CN (1) CN101056640A (es)
AR (1) AR049096A1 (es)
AU (1) AU2005244414B2 (es)
BR (1) BRPI0511135B8 (es)
CA (1) CA2564379C (es)
DE (1) DE102004024452A1 (es)
DK (1) DK1809293T3 (es)
EA (1) EA012583B1 (es)
EC (1) ECSP067004A (es)
ES (1) ES2575925T3 (es)
HU (1) HUE027780T2 (es)
IL (1) IL179218A (es)
MX (1) MXPA06013216A (es)
MY (1) MY148403A (es)
NO (1) NO20065030L (es)
PE (1) PE20060311A1 (es)
PL (1) PL1809293T3 (es)
SG (1) SG152265A1 (es)
TW (1) TWI356703B (es)
UA (1) UA87312C2 (es)
UY (1) UY28891A1 (es)
WO (1) WO2005110421A2 (es)
ZA (1) ZA200607462B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7056916B2 (en) 2002-11-15 2006-06-06 Boehringer Ingelheim Pharma Gmbh & Co. Kg Medicaments for the treatment of chronic obstructive pulmonary disease
US7220742B2 (en) 2004-05-14 2007-05-22 Boehringer Ingelheim International Gmbh Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments
MX2008001976A (es) 2005-08-15 2008-03-25 Boehringer Ingelheim Int Procedimiento para la preparacion de betamimeticos.
BRPI0618370A2 (pt) * 2005-11-09 2011-08-30 Boehringer Ingelheim Int formulação aerossol de medicamento, uso do mesmo e kit de inalação
UY30543A1 (es) * 2006-08-18 2008-03-31 Boehringer Ingelheim Int Formulacion de aerosol para la inhalacion de beta- agonistas
EP2358350A1 (en) * 2008-11-21 2011-08-24 Boehringer Ingelheim International GmbH Aerosol formulation for the inhalation of beta agonists
WO2010057927A1 (en) * 2008-11-21 2010-05-27 Boehringer Ingelheim International Gmbh Aerosol formulation for the inhalation of beta agonists
EP2906218B1 (en) 2012-10-09 2016-12-14 Boehringer Ingelheim International GmbH Beta-2-adrenoceptor agonist for the treatment of cough
CN110062625A (zh) 2016-12-12 2019-07-26 勃林格殷格翰国际有限公司 尼达尼布通过与奥达特罗共给予用于治疗间质性肺病的方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3134590A1 (de) * 1981-09-01 1983-03-10 Boehringer Ingelheim KG, 6507 Ingelheim Neue benzo-heterocyclen
US4460581A (en) * 1982-10-12 1984-07-17 Boehringer Ingelheim Kg (1-Hydroxy-2-amino-alkyl)-substituted benzoxazinones and benzoxazolinones
JPH0637388B2 (ja) * 1986-02-17 1994-05-18 千寿製薬株式会社 水性液剤
GB9405019D0 (en) * 1994-03-15 1994-04-27 Smithkline Beecham Plc Novel compounds
DE10253282A1 (de) * 2002-11-15 2004-05-27 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Arzneimittel zur Behandlung von chronisch obstruktiver Lungenerkrankung
KR101287460B1 (ko) * 2004-04-22 2013-07-23 베링거 인겔하임 인터내셔날 게엠베하 벤즈옥사진을 함유하는 호흡기 질환 치료용 약제학적배합물
DE102004019539A1 (de) * 2004-04-22 2005-11-10 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Arzneimittel zur Behandlung von Atemwegserkrankungen
DE102004024454A1 (de) * 2004-05-14 2005-12-08 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Enantiomerenreine Betaagonisten, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
DE102004024451A1 (de) * 2004-05-14 2005-12-22 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pulverformulierungen für die Inhalation, die Enantiomerenreine Betaagonisten enthalten

Also Published As

Publication number Publication date
MY148403A (en) 2013-04-30
CA2564379C (en) 2013-07-30
AR049096A1 (es) 2006-06-28
ES2575925T3 (es) 2016-07-04
EA200602017A1 (ru) 2007-06-29
ECSP067004A (es) 2007-02-28
CN101056640A (zh) 2007-10-17
HUE027780T2 (en) 2016-11-28
TWI356703B (en) 2012-01-21
KR101288791B1 (ko) 2013-07-29
DK1809293T3 (en) 2016-06-20
IL179218A0 (en) 2007-03-08
IL179218A (en) 2012-10-31
JP2007537188A (ja) 2007-12-20
EP1809293A2 (de) 2007-07-25
WO2005110421A2 (de) 2005-11-24
PL1809293T3 (pl) 2016-09-30
BRPI0511135B8 (pt) 2021-05-25
UA87312C2 (ru) 2009-07-10
CA2564379A1 (en) 2005-11-24
DE102004024452A1 (de) 2005-12-08
EP1809293B1 (de) 2016-03-16
SG152265A1 (en) 2009-05-29
UY28891A1 (es) 2005-12-30
JP4620730B2 (ja) 2011-01-26
MXPA06013216A (es) 2007-02-08
WO2005110421A3 (de) 2006-03-16
PE20060311A1 (es) 2006-05-08
AU2005244414B2 (en) 2010-12-09
EA012583B1 (ru) 2009-10-30
ZA200607462B (en) 2008-06-25
BRPI0511135A (pt) 2007-11-27
KR20070022084A (ko) 2007-02-23
TW200608981A (en) 2006-03-16
BRPI0511135B1 (pt) 2019-11-12
AU2005244414A1 (en) 2005-11-24

Similar Documents

Publication Publication Date Title
NO20065030L (no) Aerosolformulering for inhalering av beta agonister.
NO20090407L (no) Aerosolformulering for inhalering av beta agonister
NO20025821L (no) 2-aminokarbonyl-9H-purinderivater
NO20062491L (no) Benzoksazinderivter og deres anvendelse
NO20090410L (no) Aerosolformuleringer for inhalaering av beta-agonister
NO20050828L (no) lndol-3-svovelderivater
TW200730178A (en) Aerosol formulations for the inhalation of β-agonists
ATE301653T1 (de) Pyrazolopyridine
ATE296826T1 (de) Pyrazolo(1,5)pyridinderivate
AU2003228770A8 (en) Substituted pyrazolopyrimidines
ATE433447T1 (de) Pyrimiidinverbindungen
TR200302242T2 (tr) Protein kinaz önleyicileri olarak pirolopirimidinler
NO20060146L (no) Benzimidazolderivater, sammensetninger som inneholder slike, fremstilling derav og anvendelse derav
NO20065060L (no) Farmasoytiske kombinasjoner inneholdende benzoksazin for behandling av respiratoriske forstyrrelser
NO20061839L (no) Benzimidazolderivater, sammensetninger inneholdende dem, fremstilling derav, og anvendelse derav
ATE332301T1 (de) Antivirale pyrazolopyridin verbindungen
NO20060147L (no) Benzimidazolderivater, sammensetninger som inneholder slike, fremstilling derav og anvendelse derav
WO2004100865A3 (en) New benzimidazole derivatives
WO2006096444A3 (en) Chemical compounds
ATE300541T1 (de) Pyrazolopyridinderivate
NO20040881L (no) Orale antidiabetes midler.
NO20072089L (no) Benzimidazolderivater, sammensetninger som inneholder dem, fremstilling derav og anvendelse derav
NO20055749L (no) Sulfamat benzotiofenderivater som steroid sulfatase inhibitorer
NO20081587L (no) Aerosolformulering for inhalering
NO20022123L (no) Osoksazolderivater for anvendelse som inhibitorer for fosfodiesterase VII

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application